SCHEMBL27809705

SCHEMBL27809705

NCc1ccc(OCc2ccccc2)c(C(CC(=O)O)c2ccccc2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
CFD P00746 1/20 0.46
PLG P00747 1/20 0.46
PLAU P00749 1/20 0.46
F11 P03951 1/20 0.46
KLKB1 P03952 1/20 0.46
F7 P08709 1/20 0.46
TPSB2 P20231 1/20 0.46
FFAR1 O14842 2/20 0.44
FFAR4 Q5NUL3 1/20 0.44
CTSA P10619 2/20 0.43
FOLH1 Q04609 1/20 0.43
SLC6A9 P48067 1/20 0.42
SLC6A5 Q9Y345 1/20 0.42
MAOB P27338 1/20 0.41
TRPM8 Q7Z2W7 1/20 0.41
PTGER1 P34995 1/20 0.40
PTGER4 P35408 1/20 0.40
PTGER3 P43115 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27809704 1.00 KMT2A (0.49) KMT2ASMN1; SMN2CFDPLGPLAU
SCHEMBL1990399 0.89 KMT2A (0.47) KMT2ASMN1; SMN2FFAR1FFAR4CTSA
SCHEMBL1990402 0.89 KMT2A (0.47) KMT2ASMN1; SMN2FFAR1FFAR4CTSA
SCHEMBL1989783 0.85 KMT2A (0.44) KMT2ASMN1; SMN2FFAR1FFAR4CTSA
SCHEMBL2167632 0.84 KMT2A (0.47) KMT2ASMN1; SMN2FOLH1PTGER1
SCHEMBL2166135 0.84 KMT2A (0.47) KMT2ASMN1; SMN2FOLH1PTGER1
SCHEMBL1990350 0.84 PTGER1 (0.51) KMT2ASMN1; SMN2FFAR1FFAR4CTSA
SCHEMBL1783943 0.84 KMT2A (0.47) KMT2ASMN1; SMN2FOLH1PTGER1
SCHEMBL1990348 0.84 PTGER1 (0.51) KMT2ASMN1; SMN2FFAR1FFAR4CTSA
SCHEMBL27809813 0.82 MAOB (0.41) KMT2ASMN1; SMN2CFDPLGPLAU

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102089262-A Derivatives of 3- (2-hydroxy-5-methylphenyl) -N, N-diisopropyl-3-amphetamine and methods of use thereof CONCERT PHARMACEUTICALS INC 2011-06-08 CN disclosed